Pfizer Grant Request for Proposals on Prostate Cancer Education

This document is a Request for Proposals (RFP) issued by Pfizer for independent medical education grants focused on prostate cancer. The program aims to support educational initiatives for healthcare teams involved in managing patients with metastatic prostate cancer (mPC), specifically through the integration of targeted therapies and testing into clinical practice. The RFP outlines the eligibility criteria for applicants, which include medical and healthcare institutions, professional organizations, and educational entities. It specifies that projects should address educational gaps related to guideline-concordant care and the management of targeted therapies. Key areas of interest include the efficacy and safety of PARP inhibitors (PARPi), best practices for implementing genetic testing, and strategies for engaging patients in treatment decisions. The funding range for individual projects is between $5,000 and $250,000, with a total budget of $500,000 available for this initiative. Important dates for submission and project timelines are also provided.